1,555 Axon Enterprise, Inc $AXON Shares Purchased by First Pacific Financial

First Pacific Financial increased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 7,775.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,575 shares of the biotechnology company’s stock after purchasing an additional 1,555 shares during the quarter. First Pacific Financial’s holdings in Axon Enterprise were worth $665,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Pure Financial Advisors LLC raised its position in Axon Enterprise by 6.7% during the 4th quarter. Pure Financial Advisors LLC now owns 364 shares of the biotechnology company’s stock worth $207,000 after buying an additional 23 shares during the last quarter. Keel Point LLC lifted its stake in Axon Enterprise by 4.4% during the 1st quarter. Keel Point LLC now owns 599 shares of the biotechnology company’s stock valued at $254,000 after acquiring an additional 25 shares during the period. Bridgewater Advisors Inc. lifted its stake in Axon Enterprise by 4.4% during the 2nd quarter. Bridgewater Advisors Inc. now owns 616 shares of the biotechnology company’s stock valued at $352,000 after acquiring an additional 26 shares during the period. Roman Butler Fullerton & Co. boosted its holdings in shares of Axon Enterprise by 2.4% in the 1st quarter. Roman Butler Fullerton & Co. now owns 1,278 shares of the biotechnology company’s stock valued at $500,000 after acquiring an additional 30 shares during the last quarter. Finally, 44 Wealth Management LLC boosted its holdings in shares of Axon Enterprise by 6.0% in the 1st quarter. 44 Wealth Management LLC now owns 530 shares of the biotechnology company’s stock valued at $225,000 after acquiring an additional 30 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Zacks Research upgraded shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Monday, October 5th. Piper Sandler raised their target price on shares of Axon Enterprise from $724.00 to $732.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Needham & Company LLC restated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, September 2nd. Argus upped their price target on shares of Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, September 3rd. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $721.57.

Axon Enterprise Trading Down 1.2%

AXON stock opened at $408.42 on Thursday. The company’s 50-day simple moving average is $507.31 and its 200-day simple moving average is $475.11. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. Axon Enterprise, Inc has a 52-week low of $339.01 and a 52-week high of $764.02. The firm has a market cap of $33.18 billion, a P/E ratio of 169.47, a PEG ratio of 7.78 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The firm had revenue of $904.39 million for the quarter, compared to analysts’ expectations of $876.42 million. During the same period last year, the firm earned $2.12 EPS. The company’s quarterly revenue was up 35.3% on a year-over-year basis. As a group, equities analysts forecast that Axon Enterprise, Inc will post 2.12 EPS for the current fiscal year.

Insiders Place Their Bets

In other Axon Enterprise news, insider Isaiah Fields sold 1,017 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $480.45, for a total value of $488,617.65. Following the sale, the insider directly owned 56,264 shares of the company’s stock, valued at approximately $27,032,038.80. This trade represents a 1.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey Kunins sold 9,605 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the sale, the insider owned 97,761 shares of the company’s stock, valued at $61,266,818.70. This trade represents a 8.95% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 47,397 shares of company stock worth $26,722,984. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.

The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.

Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.